Boehringer Ingelheim

EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod
Fierce Pharma
Tue, 09/17/19 - 11:00 am
Eli Lilly
Boehringer Ingelheim
Jardiance
kidney disease
JNJ
EASD
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Novo Nordisk
diabetes
ICER
oral semaglutide
Eli Lilly
Boehringer Ingelheim
Jardiance
Ozempic
Boehringer Ingelheim’s Ofev secures FDA approval for SSc-ILD
Pharmaceutical Business Review
Mon, 09/9/19 - 10:32 am
Ofev
SSc-ILD
Boehringer Ingelheim
FDA
After inking a string of pipeline deals, Boehringer Ingelheim is doing a makeover of the top executive team
Endpoints
Mon, 08/26/19 - 10:53 pm
Boehringer Ingelheim
R&D
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
Sun, 08/25/19 - 05:10 pm
drug pricing
Canada
Janssen
Merck
Bayer
Servier
Boehringer Ingelheim
MD Anderson and Boehringer Ingelheim to Partner on Cancer, Found a Virtual R&D Center
BioSpace
Mon, 08/12/19 - 05:29 pm
Boehringer Ingelheim
MD Anderson Cancer Center
cancer
R&D
Boehringer posts solid first half as business revamp beds in
PM Live
Fri, 08/2/19 - 11:44 pm
Boehringer Ingelheim
earnings
Spiriva
Jardiance
Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M
Fierce Biotech
Thu, 07/18/19 - 11:38 am
Boehringer Ingelheim
Bridge Biotherapeutics
Ofeva
IPF
BBT-877
Boehringer buys up cancer vaccine player, eyes oncology combo strategy
Fierce Biotech
Mon, 07/15/19 - 10:05 am
Boehringer Ingelheim
M&A
Amal Therapeutics
Boehringer races to catch up in NASH through Yuhan deal
BioCentury
Mon, 07/1/19 - 10:47 pm
Boehringer Ingelheim
NASH
Yuhan
FDA fast-tracks BI, Lilly's Jardiance in chronic heart failure
Fierce Pharma
Wed, 06/26/19 - 04:59 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
chronic heart failure
fast track
Boehringer leads investment in digital therapy for myopia
Pharmaforum
Fri, 06/21/19 - 09:48 am
Dopavision
Boehringer Ingelheim
myopia
digital medicine
digital therapy
Boehringer, OSE doses first patient in phase 1 trial of SIRPα antagonist monoclonal antibody
Pharmaceutical Business Review
Tue, 06/18/19 - 09:56 am
Boehringer Ingelheim
OSE Immuotherapeutics
clinical trials
BI 765063
solid tumors
Boehringer Ingelheim opens inhaler plant with 200 jobs
Fierce Pharma
Mon, 06/17/19 - 11:34 pm
Boehringer Ingelheim
inhalers
drug manufacturing
Spain
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Tue, 06/11/19 - 12:06 pm
Eli Lilly
Boehringer Ingelheim
ADA
diabetes
Tradjenta
Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Pharmaceutical Business Review
Thu, 05/30/19 - 10:05 am
obesity
peptide poly-agonists
Boehringer Ingelheim
Gubra
Boehringer looks to enhance COPD care with new registry
Pharmaforum
Fri, 05/24/19 - 10:52 am
Boehringer Ingelheim
COPD
patients
patient registry
AbbVie stock up 1.3% after announcing resolution to litigation over Humira in the U.S.
Marketwatch
Tue, 05/14/19 - 09:31 am
AbbVie
biosimilars
Humira
patents
Boehringer Ingelheim
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
Fierce Pharma
Thu, 05/9/19 - 11:04 pm
gangrene
diabetes
JNJ
Invokana
AstraZeneca
Farxiga
Eli Lilly
Boehringer Ingelheim
Jardiance
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Fri, 04/19/19 - 10:34 am
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure

Pages